This announcement is a separate document:
关于子公司注射用头孢唑肟钠通过仿制药一致性评价的公告
Announcement regarding the subsidiary's cephalosporin injection sodium sulbactam passing the generic consistency evaluation.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.